Leaflet TIPERANT 125mg / 80mg capsules

Product code:
W65440001
Quantity:
1
Indicated for:
chemotherapy-induced nausea and vomiting
Route of administration:
oral
Substance:
aprepitant (antiemetic)
ATC
A04AD12 — Alimentary tract and metabolism | Antiemetics and antinauseants | Antiemetics and antinauseants | Other antiemetics
Aprepitant is a neurokinin-1 (NK1) receptor antagonist used in the prevention of chemotherapy-induced or postoperative nausea and vomiting. It works by blocking NK1 receptors in the central nervous system, thereby preventing the effects of substance P, a neurotransmitter involved in the vomiting reflex.

Aprepitant is administered orally, usually in combination with other antiemetic medications such as corticosteroids and 5-HT3 receptor antagonists. It is commonly used in chemotherapy regimens with high emetogenic potential.

Common side effects include fatigue, constipation, diarrhea, and loss of appetite. In rare cases, allergic reactions or elevated liver enzymes may occur.

Aprepitant is an important therapeutic option for patients undergoing chemotherapy, helping to improve treatment tolerance and maintain their quality of life.

General data about TIPERANT 125mg / 80mg

Substance:
aprepitant
Date of latest medicines list:
19-03-2019
Product code:
W65440001
Concentration:
125mg / 80mg
Pharmaceutical form:
capsules
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ETHYPHARM - FRANTA
Holder:
ETHYPHARM - FRANTA
Number:
11049/2018/01
Shelf life:
30 months

Concentrations available for aprepitant

  • 125mg
  • 125mg/80mg
  • 40mg
  • 80mg